You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 157 No. 10, 26 MAY 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (95)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Heart Failure Treatment With Angiotensin-Converting Enzyme Inhibitors in Hospitalized Medicare Patients in 10 Large States

The Large State Peer Review Organization Consortium

Arch Intern Med. 1997;157(10):1103-1108.


Abstract

Background
Angiotensin-converting enzyme (ACE) inhibitors have been proved to reduce mortality, rates of hospitalization, and disease progression in patients with heart failure. Investigators have suggested that ACE inhibitors are underused in heart failure.

Methods
We examined the use of ACE inhibitors and the documentation of cardiac ejection fractions (EFs) in Medicare patients admitted to acute care hospitals with a principal diagnosis of heart failure. A random sample of at least 600 medical records in each of 10 populous states was retrospectively abstracted by peer review organizations. A total of 6749 records were reviewed of patients aged 65 years and older who were discharged in 1993 and 1994. The review tool was adapted from the Heart Failure Guidelines disseminated by the Agency for Health Care Policy and Research. An ideal candidate cohort was created of patients most likely to benefit from ACE inhibitors on the basis of their EF values (<40%), renal function, absence of hyperkalemia, and absence of other contraindications.

Results
Fifty-five percent (95% confidence interval, 54%-56%) of patients received ACE inhibitors at discharge. In the ideal candidate group, 73% (95% confidence interval, 71%-75%) of patients received ACE inhibitors at discharge. The oldest group was least likely to have ACE inhibitors prescribed at discharge. The EF was documented in 59% (95% confidence interval, 58%-60%) of records.

Conclusions
Medicare chart review suggests under-use of ACE inhibitors in up to one quarter of patients who have no clear contraindications. A substantial number of patients without documented EF are also likely to benefit from the use of ACE inhibitors.

Arch Intern Med. 1997;157:1103-1108



Author Affiliations

From the Large State Peer Review Organization Consortium. Members of the Consortium are listed at the end of the article.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II
Komajda et al.
Eur Heart J 2009;30:478-486.
ABSTRACT | FULL TEXT  

Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey
de Groote et al.
Eur J Heart Fail 2007;9:1205-1211.
ABSTRACT | FULL TEXT  

Management of octogenarians hospitalized for heart failure in Euro Heart Failure Survey I
Komajda et al.
Eur Heart J 2007;28:1310-1318.
ABSTRACT | FULL TEXT  

Effects of Nurse Management on the Quality of Heart Failure Care in Minority Communities: A Randomized Trial
Sisk et al.
ANN INTERN MED 2006;145:273-283.
ABSTRACT | FULL TEXT  

Comparison of treatment of patients with congestive heart failure by cardiologists versus noncardiologists
Patel and Fotis
Am J Health Syst Pharm 2005;62:168-172.
ABSTRACT | FULL TEXT  

National Patterns of Use and Effectiveness of Angiotensin-Converting Enzyme Inhibitors in Older Patients With Heart Failure and Left Ventricular Systolic Dysfunction
Masoudi et al.
Circulation 2004;110:724-731.
ABSTRACT | FULL TEXT  

Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital discharge
Butler et al.
J Am Coll Cardiol 2004;43:2036-2043.
ABSTRACT | FULL TEXT  

Outcomes and the quality of care for patients hospitalized with heart failure
Luthi et al.
Int J Qual Health Care 2004;16:201-210.
ABSTRACT | FULL TEXT  

One-year follow-up of heart failure patients after their first admission
Formiga et al.
QJM 2004;97:81-86.
ABSTRACT | FULL TEXT  

Incremental value of myocardial viability for prediction of Long-Term prognosis in surgically revascularized patients with left ventricular dysfunction
Sawada et al.
J Am Coll Cardiol 2003;42:2099-2105.
ABSTRACT | FULL TEXT  

Falls, chronic diseases, and drug use in elderly women: Lack of association may be explained
Epstein
BMJ 2003;327:1288-1288.
FULL TEXT  

Readmissions and the quality of care in patients hospitalized with heart failure
Luthi et al.
Int J Qual Health Care 2003;15:413-421.
ABSTRACT | FULL TEXT  

Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality
Kittleson et al.
J Am Coll Cardiol 2003;41:2029-2035.
ABSTRACT | FULL TEXT  

HOPE Study Impact on ACE Inhibitors Use
Hemels et al.
The Annals of Pharmacotherapy 2003;37:640-645.
ABSTRACT | FULL TEXT  

Elderly Hospitalized Patients With Diastolic Heart Failure: Lack of Gender and Ethnic Differences in 18-Month Mortality Rates
Ibrahim et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2003;58:M56-59.
ABSTRACT | FULL TEXT  

Prevalence, Expenditures, and Complications of Multiple Chronic Conditions in the Elderly
Wolff et al.
Arch Intern Med 2002;162:2269-2276.
ABSTRACT | FULL TEXT  

The Effect of External Feedback on the Management of Medicare Inpatients With Congestive Heart Failure
Hayes et al.
American Journal of Medical Quality 2002;17:225-235.
ABSTRACT  

Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors
Maggioni et al.
J Am Coll Cardiol 2002;40:1414-1421.
ABSTRACT | FULL TEXT  

Angiotensin receptor blockers in heart failure: A work in progress
Greenberg
J Am Coll Cardiol 2002;40:1422-1424.
FULL TEXT  

Left Ventricular Ejection Fraction Test Rates for Medicare Beneficiaries With Heart Failure
Wu and Pope
American Journal of Medical Quality 2002;17:61-66.
ABSTRACT  

Acute Precipitants of Congestive Heart Failure Exacerbations
Tsuyuki et al.
Arch Intern Med 2001;161:2337-2342.
ABSTRACT | FULL TEXT  

Quality of congestive heart failure treatment at a Canadian teaching hospital
Weil and Tu
CMAJ 2001;165:284-287.
ABSTRACT | FULL TEXT  

Coronary Heart Disease in the First 30 Years of the 21st Century: Challenges and Opportunities : The 33rd Annual James B. Herrick Lecture of the Council on Clinical Cardiology of the American Heart Association
Beller
Circulation 2001;103:2428-2435.
FULL TEXT  

Specialty-related differences in the epidemiology, clinical profile, management and outcome of patients hospitalized for heart failure. The OSCUR study
Bellotti et al.
Eur Heart J 2001;22:596-604.
ABSTRACT  

Toleration of High Doses of Angiotensin-Converting Enzyme Inhibitors in Patients With Chronic Heart Failure: Results From the ATLAS Trial
Massie et al.
Arch Intern Med 2001;161:165-171.
ABSTRACT | FULL TEXT  

Impact of a Guideline-Based Disease Management Team on Outcomes of Hospitalized Patients With Congestive Heart Failure
Costantini et al.
Arch Intern Med 2001;161:177-182.
ABSTRACT | FULL TEXT  

Progress in Heart Failure Management? : Lessons from the Real World
Konstam
Circulation 2000;102:1076-1078.
FULL TEXT  

Evaluating Quality of Care for Patients With Heart Failure
Krumholz et al.
Circulation 2000;101 :e122-e140.
FULL TEXT  

Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry
Bart et al.
Eur Heart J 1999;20:1182-1190.
ABSTRACT  

Heart Failure Survival Among Older Adults in the United States: A Poor Prognosis for an Emerging Epidemic in the Medicare Population
Croft et al.
Arch Intern Med 1999;159:505-510.
ABSTRACT | FULL TEXT  

Angiotensin-Converting Enzyme Inhibitors for Elderly Patients With Congestive Heart Failure
Gambassi et al.
Arch Intern Med 1998;158:97-98.
FULL TEXT  

Underutilization of Evidence-Based Therapy in Heart Failure: An Opportunity to Deal a Winning Hand With Ace up Your Sleeve
Deedwania
Arch Intern Med 1997;157:2409-2412.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.